2bPrecise, an Allscripts company, launches a Genomics and
Precision Medicine Initiative at National Institutes of Health
Leading physicians in genomic medicine to use the 2bPrecise clinical-genomic
solution to improve patient diagnosis, advance medical research
CHICAGO – August 8, 2016 – 2bPrecise LLC, a wholly owned subsidiary of Allscripts
Healthcare Inc. (Allscripts) (NASDAQ:MDRX), has launched a strategic early adopter program
at the National Institutes of Health (NIH), America’s leading Care Institution for clinical research
and a long-time Allscripts Sunrise™ client. The program will focus on deploying a cloud-based
genomics and precision medicine solution designed by 2bPrecise.
The 2bPrecise EHR Agnostic solution will enable physicians and researchers to use genomic
information in their current Allscripts Sunrise™ workflow, simplifying and optimizing the complex
process of finding, selecting, ordering and receiving genomic tests. Using the 2bPrecise
genomics and precision medicine solution, results of genomic sequencing tests will be made
available and actionable at the point of care through Allscripts Sunrise™ electronic health
record (EHR).
Experts from NIH in the field of genomic medicine will be the early adopters of the 2bPrecise
solution. Users of the program will pan across the National Human Genome Research Institute,
the National Cancer Institute and the NIH Clinical Center.
“We are honored and excited to work with NIH, one of the most innovative research institutions
in the world, on this dimensional change of health care. 2bPrecise will soon be able to take a
big step toward bringing an easy-to-use, clinical-genomic solution into the mainstream,” said
2bPrecise General Manager Assaf Halevy. Soon, this solution offering will be available to any
provider, integrated delivery network or payer organization who wants to advance the research
that will unlock new insights of molecular diagnostics and new treatments.
In addition to improving the workflow experience for physicians and nurses, the 2bPrecise
solution uses advanced methods in clinical-genomic ontology and data harmonization and will
return merged, semantically harmonized knowledge in a machine-readable and structured
format. Medical researchers can combine genomic data with clinical and environmental
information in a manner that enables statistical analysis and pattern detection.
About the National Institutes of Health (NIH)
NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the
U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and
supporting basic, clinical, and translational medical research, and is investigating the causes, treatments,
and cures for both common and rare diseases. For more information about NIH and its programs,
visit www.nih.gov.
About 2bPrecise
A fully owned subsidiary of Allscripts, 2bPrecise addresses the challenge of enabling clinical utilization of
‘precision medicine’ data by delivering actionable, interpreted, and patient-specific information in a
readable and computable format within a provider’s existing clinical workflow, truly facilitating decisionmaking at the point of care.
The cloud-based precision-medicine platform harmonizes genomic, clinical, and lifestyle data and brings
precise, EMR-agnostic, in-workflow interventions that work seamlessly within existing provider workflow.
Learn more at www.2bPrecisehealth.com.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance
clinical, financial and operational results. Our innovative solutions connect people, places and data across
an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions
and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter,
YouTube and It Takes A Community: The Allscripts Blog.
###
© 2016 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or
its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to
these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or
its affiliates.
2bPrecise, the 2bPrecise logo, and other 2bPrecise marks are trademarks of 2bPrecise, LLC and/or its
affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to
these products is not intended to imply affiliation with or sponsorship of 2bPrecise, LLC and/or its affiliates.
For more information, contact:
Investors:
Seth Frank
312-506-1213
[email protected]
Media:
Concetta DiFranco
312-447-2466
[email protected]